CDH2 and cancer: EMT is a progression where cells can lose their epithelial properties like E-cadherin and a few more and gain mesenchymal properties like CDH2, VIM, FN1, etc. EMT has long been investigated for its involvement in cancer treatment resistance and metastasis.